QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aethlon-medical-reports-early-signals-from-hemopurifier-trial-in-cancer-patients-showing-immune-and-molecular-shifts-in-first-cohort

Aethlon Medical, Inc. ("Aethlon" or the "Company") (NASDAQ:AEMD) today provided observations on the preliminary...

 aethlon-medical-announces-45m-equity-offering-5m-shares-and-warrants-priced-at-090shr

Aethlon Medical, Inc. ("Aethlon" or the "Company") (NASDAQ:AEMD), a medical therapeutic company focused on deve...

 aethlon-medical-shares-soar-after-new-securities-offering-filing

Aethlon Medical shares are trading higher Thursday after the company moved forward with plans for a new securities offering.

 aethlon-medical-files-for-offering-of-common-stock-and-accompanying-warrants-size-not-disclosed

-SEC Filing

 hc-wainwright--co-reiterates-neutral-on-aethlon-medical-maintains-15-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Aethlon Medical (NASDAQ:AEMD) with a Neutral and maintains...

 aethlon-medical-q1-eps-085-beats-086-estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(0.8...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION